herpes zoster
Conditions
Interventions
Control Group:Standardized use of Acyclovir Injection, Pruribarin Capsules, and Topical Acyclovir Cream
Treatment Group:The control group received medication combined with injection at the Jiaji acupoint.
Sponsors
Chen Shaoning
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1.Age =18 years, gender unrestricted; 2. Meeting the diagnostic criteria for herpes zoster, acute phase patients; 3. Voluntary participation in the study with signed informed consent; 4. Complete clinical data available for follow-up.
Exclusion criteria
Exclusion criteria: Severe cardiac, hepatic, or renal diseases; immunodeficiency; pregnancy; allergies; skin infections, etc. 1.Patients with severe cardiac, hepatic, renal, or immune dysfunction; 2. Pregnant or lactating women; 3. Individuals with hypersensitivity to the investigational drug; 4. Patients with skin ulceration, infection, or intolerance to acupoint injection; 5. Patients with mental disorders or cognitive impairment who cannot cooperate with treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| The skin lesions have subsided.; Incidence of postherpetic neuralgia;length of stay; Hospitalization costs; | — |
Countries
China
Contacts
Public ContactChen Shaoning
Department of Dermatology, Hanzhong Railway Central Hospital
Outcome results
None listed